» Articles » PMID: 22978559

Expression of Peptidylarginine Deiminase-2 and -4, Citrullinated Proteins and Anti-citrullinated Protein Antibodies in Human Gingiva

Overview
Specialty Dentistry
Date 2012 Sep 18
PMID 22978559
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: The presence of citrullinated proteins, and peptidylarginine deiminase types -2 (PAD-2) and -4 (PAD-4) in periodontal tissues, determine the presence of anti-cyclic citrullinated protein antibodies (anti-CCP) in gingival crevicular fluid (GCF) and compare the expression of these proteins between inflamed and non-inflamed sites.

Material And Methods: Tissue sections were stained using antibodies against citrullinated proteins, PAD-2 and PAD-4. RT-PCR was performed to investigate PAD-2 and PAD-4 mRNA in inflamed and non-inflamed gingival tissues. Anti-CCP antibodies in gingival crevicular fluid were detected by ELISA.

Results: Citrullinated proteins, PAD-2 and PAD-4 were detected in gingiva. There was a correlation between inflammation and expression of these proteins. mRNAs for PAD-2 and PAD-4 were detected in both inflamed and non-inflamed gingival tissues. Antibodies to CCP were found mostly in the GCF of individuals with periodontitis.

Conclusion: PAD-2 and PAD-4 (protein and mRNA) as well as citrullinated proteins are present in inflamed gingiva, and anti-CCP antibodies can be detected in the GCF of some patients. Tissue expression of citrullinated proteins and PAD increased with the severity of inflammation. The presence of anti-CCP antibodies in GCF was almost exclusive to a subset of patients with periodontitis. Increased expression of these proteins in inflamed gingiva lends support to the notion that periodontal inflammation contributes to the inflammatory burden in a similar way to rheumatoid arthritis.

Citing Articles

associates with the presence of anti-citrullinated protein antibodies, but not with the onset of arthritis: studies in an at-risk population.

de Vries C, Circiumaru A, Mathsson-Alm L, Westerlind H, Dehara M, Kisten Y RMD Open. 2025; 11(1).

PMID: 39890206 PMC: 11792289. DOI: 10.1136/rmdopen-2024-005111.


Food-derived bioactive peptides potentiating therapeutic intervention in rheumatoid arthritis.

Liu C, Yan Z, Zhang X, Xia T, Ashaolu J, Olatunji O Heliyon. 2024; 10(10):e31104.

PMID: 38778960 PMC: 11109807. DOI: 10.1016/j.heliyon.2024.e31104.


Effect of Chronic Rhinosinusitis on the Risk of Development of Rheumatoid Arthritis.

Lee I, Yang H, Ha S, Son G, Kim D, Kim D Allergy Asthma Immunol Res. 2023; 15(5):647-658.

PMID: 37827981 PMC: 10570781. DOI: 10.4168/aair.2023.15.5.647.


Periodontitis and periodontopathic bacteria as risk factors for rheumatoid arthritis: A review of the last 10 years.

Kobayashi T, Bartold P Jpn Dent Sci Rev. 2023; 59:263-272.

PMID: 37674898 PMC: 10477376. DOI: 10.1016/j.jdsr.2023.08.002.


New insights into inflammatory osteoclast precursors as therapeutic targets for rheumatoid arthritis and periodontitis.

Hascoet E, Blanchard F, Blin-Wakkach C, Guicheux J, Lesclous P, Cloitre A Bone Res. 2023; 11(1):26.

PMID: 37217496 PMC: 10203317. DOI: 10.1038/s41413-023-00257-w.